On the one hand, FASN expression appears to be part of an estradiol-driven cellular response that leads to tamoxifen-preventable proliferation of luminal A breast cancer cells; exposure of hormone-responsive breast cancer cells to estradiol significantly up-regulates FASN protein expression in an ERα-dependent manner. This evidence concerns the gene ESR1 and breast carcinoma.